SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $293,000 | -14.3% | 6,602 | +9.6% | 0.01% | -25.0% |
| Q2 2021 | $342,000 | +2.1% | 6,026 | +34.5% | 0.01% | +14.3% |
| Q1 2021 | $335,000 | -16.9% | 4,481 | -3.9% | 0.01% | -12.5% |
| Q4 2020 | $403,000 | +30.8% | 4,663 | -7.5% | 0.01% | 0.0% |
| Q3 2020 | $308,000 | +48.8% | 5,042 | +1.1% | 0.01% | +33.3% |
| Q2 2020 | $207,000 | -31.2% | 4,986 | -50.1% | 0.01% | -73.9% |
| Q2 2016 | $301,000 | -60.0% | 10,000 | -33.3% | 0.02% | -30.3% |
| Q1 2015 | $753,000 | – | 15,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |